37Th International Winter-Workshop Clinical, Chemical and Biochemical Aspects of Pteridines and Related Topics 43
Pteridines 2018; 29: 42–69 Abstracts Open Access Fuchs D (Innsbruck, Austria), Gostner JM (Innsbruck, Austria), Griesmacher A (Innsbruck, Austria), Melichar B (Olomouc, Czech Republic), Reibnegger G (Graz, Austria), Weiss G (Innsbruck, Austria), Werner ER (Innsbruck, Austria) 37th International Winter-Workshop Clinical, Chemical and BiochemicalJournal xyz 2017; Aspects1 (2): 122–135 of Pteridines The Firstand Decade Related (1964-1972) Topics Research Article Innsbruck, February 20th – 23rd, 2018 Max Musterman, Paul Placeholder Whathttps://doi.org/10.1515/pteridines-2018-0006 Is So Different About received April 13, 2018; accepted May 8, 2018. Primary criterion of evaluation was the forced Neuroenhancement? expiratory volume in the first second (FEV1). Secondary Was ist so anders am Neuroenhancement?criteria were subjective sensations, further lung function parameters such as airway resistance, physical Tolerability of inhaled N-chlorotaurine examination, and blood analyses (gases, electrolytes, Pharmacological and Mental Self-transformation in Ethic – a phase I clinical study organ function values, pharmacokinetic parameters Comparison taurine and methionine, immune parameters). PharmakologischeArnitz A, Stein M, und Bauer mentale P, Lanthaler Selbstveränderung B, Jamnig H, Scholl- im All included 15 females and 9 males completed the ethischenBürgi VergleichS, Stempfl-Al-Jazrawi K, Ulmer H, Baumgartner B, treatment and the control examinations according to the Embacher S, Geisler S, Gostner JM, Müllinger B, Kälz B, Nagl M study protocol. FEV1 and all other objective parameters https://doi.org/10.1515/xyz-2017-0010District Hospital Vöcklabruck, Department of Pneumology, remained unchanged and constant during the treatment received Vöcklabruck,February 9, 2013; Austria; accepted Public March Hospital25, 2013; publishedNatters, Departmentonline July 12, 2014and in control examinations 1 week and 3 months after of Pneumology, Natters, Austria; Clinical Trial Center, the treatment.
[Show full text]